title: Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells.
abstract: Activation of the Rho kinase (ROCK) pathway has been associated with inhibition of neurite regeneration and outgrowth in spinal cord injury. Growth-inhibitory substances present in the glial scar such as chondroitin sulfate proteoglycans (CSPGs) have been shown to create a nonpermissive environment for axon regeneration that results in growth cone collapse. In this study, an in vitro model was developed in nerve growth factor-differentiated PC12 cells where the Rho/ROCK pathway was modulated by CSPG. CSPG elicited concentration-dependent inhibition of neurite outgrowth in PC12 cells, which was reversed by ROCK inhibitors such as fasudil, dimethylfasudil, and Y27632. Further studies on the interactions of CSPG with ROCK inhibitors revealed that the modulation of ROCK by CSPG is noncompetitive in nature. It was also observed that ROCK inhibitors increased neurite outgrowth in undifferentiated PC12 cells, indicating constitutive ROCK activity in the cells. Analysis of signaling pathways demonstrated that the effect of CSPG increases the phosphorylation of myosin phosphatase, a substrate immediately downstream of ROCK activation. Fasudil, dimethylfasudil, and Y27632 inhibited the phosphorylation of myosin phosphatase induced by CSPG with rank order potencies comparable to those observed in the neurite outgrowth assay. In addition, ROCK inhibitors reversed cofilin phosphorylation induced by CSPG with similar rank order potencies. Taken together, our data demonstrate that the interaction of CSPG with the ROCK pathway involves downstream effectors of ROCK such as myosin phosphatase and cofilin.
authors.affiliation: Advanced Technology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, USA. sujatha.m.gopalakrishnan@abbott.com
authors.forename: Sujatha M
authors.initials: SM
authors.lastname: Gopalakrishnan
authors.forename: Nicole
authors.initials: N
authors.lastname: Teusch
authors.forename: Christiane
authors.initials: C
authors.lastname: Imhof
authors.forename: Margot H M
authors.initials: MH
authors.lastname: Bakker
authors.forename: Mark
authors.initials: M
authors.lastname: Schurdak
authors.forename: David J
authors.initials: DJ
authors.lastname: Burns
authors.forename: Usha
authors.initials: U
authors.lastname: Warrior
mesh_terms: D000818:Animals; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism*; D051338:Cofilin 1 / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D043263:Myosin-Light-Chain Phosphatase / Q000378:metabolism; D016501:Neurites / Q000187:drug effects / Q000378:metabolism*; D016716:PC12 Cells; D010766:Phosphorylation; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D054460:rho-Associated Kinases / Q000378:metabolism*
chemical_list: D011508:Chondroitin Sulfate Proteoglycans; D051338:Cofilin 1; D004791:Enzyme Inhibitors; D054460:rho-Associated Kinases; D043263:Myosin-Light-Chain Phosphatase